Skip to main content

Deze website is uitsluitend voorbehouden aan beroepsbeoefenaren in Nederland.

  1. Educatie
  2. Bron: Campus Sanofi
  3. 11 nov 2026

ECTRIMS 2026: Key Highlights

Auteur: Sanofi

Editorial Team

10th Joint ACTRIMS-ECTRIMS Meeting Toronto, 21-23 October 2026.
ECTRIMS 2026

Following ACTRIMS–ECTRIMS 2026, leading European MS experts discuss key highlights and emerging evidence with a focus on their relevance to clinical practice for neurologists in North Europe. Hosted by Professor Pietro Maggi, this webinar brings together MS experts from across Northern Europe.

Expert perspectives

Read the key topics presented by Nordic experts at MSToronto 2026, including MS progression, biomarkers, real-world data and imaging.

Prof Maggi

Prof. Pietro Maggi, MD, PhD, Associate Professor

Clinical Neurology, UCLouvain, and Neurologist, Cliniques Universitaires Saint-Luc, Brussels

  • Welcome and introduction to program and experts highlights of ECTRIMS
Zolt img

Prof. Zsolt Illés, MD, PhD, DSc

Professor, University of Southern Denmark, and Consultant Neurologist, Odense University Hospital

  • Composite of markers to predict disease progression in secondary progressive multiple sclerosis
Lars Forsberg

Lars Forsberg, PhD

Research Specialist, Karolinska Institutet

  • Advancing prediction of progression independent of relapses in multiple sclerosis by integrating clinical data and patient-reported outcomes
Friberg Emilie

Emilie Friberg, PhD, Associate Professor

Principal Researcher, Karolinska Institutet

  • Understanding MS phenotypes and economic burden (analysis from the Swedish MS Registry)
Sini Laakso-rajattu

Sini Laakso, MD, PhD, Associate Professor

Specialist in neurology, Helsinki University Hospital, and research group leader, University of Helsinki

  • MSToronto highlights: imaging updates and key takeaways
Sandgren Sofia

Sofia Sandgren, MD, PhD

Researcher, University Hospital and University of Basel; affiliated with the University of Gothenburg and Sahlgrenska University Hospital

  • Identification of new promising fluid biomarker candidates to capture progression in MS patients through targeted (Olink, Nulisa) and non-targeted (mass spectrometry) proteomics

Watch the webinar

Watch the full webinar recording in which leading European MS experts discuss key ACTRIMS–ECTRIMS 2026 highlights, moderated by Professor Pietro Maggi.

MAT-BE-2601304

Neem contact op

Get in touch - dupixent
Wij staan klaar

Heeft u vragen of wilt u meer weten? Wij zorgen dat u zo snel mogelijk geholpen wordt.

MAT-NL-2600542 v1.0 – 05/11/2026